These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Alteration in the biliary and urinary excretion of acetaminophen metabolites by nephrotoxicants in rats. Seo KW, Choung SY, Park KS, Kim HJ. Res Commun Mol Pathol Pharmacol; 1997 Mar; 95(3):305-17. PubMed ID: 9144837 [Abstract] [Full Text] [Related]
25. Stereoselective metabolism of benoxaprofen in rats. Biliary excretion of benoxaprofen taurine conjugate and glucuronide. Mohri K, Okada K, Benet LZ. Drug Metab Dispos; 1998 Apr; 26(4):332-7. PubMed ID: 9531520 [Abstract] [Full Text] [Related]
26. Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile. Heggie GD, Sommadossi JP, Cross DS, Huster WJ, Diasio RB. Cancer Res; 1987 Apr 15; 47(8):2203-6. PubMed ID: 3829006 [Abstract] [Full Text] [Related]
27. Comparison of high-pressure liquid chromatography and microbiological assay for the determination of biliary elimination of ciprofloxacin in humans. Brogard JM, Jehl F, Monteil H, Adloff M, Blickle JF, Levy P. Antimicrob Agents Chemother; 1985 Aug 15; 28(2):311-4. PubMed ID: 2939796 [Abstract] [Full Text] [Related]
28. The biliary elimination of the selective beta-receptor blocking drug talinolol in man. Terhaag B, Gramatté T, Richter K, Voss J, Feller K. Int J Clin Pharmacol Ther Toxicol; 1989 Apr 15; 27(4):170-2. PubMed ID: 2565889 [Abstract] [Full Text] [Related]
30. Pharmacokinetics of silybin in bile following administration of silipide and silymarin in cholecystectomy patients. Schandalik R, Gatti G, Perucca E. Arzneimittelforschung; 1992 Jul 15; 42(7):964-8. PubMed ID: 1329780 [Abstract] [Full Text] [Related]
33. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs. Huskey SE, Dean BJ, Doss GA, Wang Z, Hop CE, Anari R, Finke PE, Robichaud AJ, Zhang M, Wang B, Strauss JR, Cunningham PK, Feeney WP, Franklin RB, Baillie TA, Chiu SH. Drug Metab Dispos; 2004 Feb 15; 32(2):246-58. PubMed ID: 14744948 [Abstract] [Full Text] [Related]
34. [Conjugated bile acid profiles in serum, urine, and bile of patients with primary biliary cirrhosis under the ursodeoxycholic acid treatment]. Aoshima M, Nakamura K, Makino I. Hokkaido Igaku Zasshi; 1995 Jan 15; 70(1):57-67. PubMed ID: 7744371 [Abstract] [Full Text] [Related]
35. Penetration of ciprofloxacin into parotid gland tissue and parotid saliva. Maier H, Sziegoleit A, Merck S. Arzneimittelforschung; 1987 Jul 15; 37(7):797-8. PubMed ID: 3675673 [Abstract] [Full Text] [Related]
36. Relation of biliary bile acid output to hepatic adenosine triphosphate level and biliary indocyanine green excretion in humans. Chijiiwa K, Mizuta A, Ueda J, Takamatsu Y, Nakamura K, Watanabe M, Kuroki S, Tanaka M. World J Surg; 2002 Apr 15; 26(4):457-61. PubMed ID: 11910480 [Abstract] [Full Text] [Related]
37. Metabolism and excretion of atorvastatin in rats and dogs. Black AE, Hayes RN, Roth BD, Woo P, Woolf TF. Drug Metab Dispos; 1999 Aug 15; 27(8):916-23. PubMed ID: 10421619 [Abstract] [Full Text] [Related]